Cyphaira Corp. (OTCPK: CYPA)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Cyphaira Corp. (OTCPK: CYPA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $39.17M.
trading between 1.05 and 3.00.
Tweenvest scores Cyphaira Corp. across four factors: quality 33/100, value 52/100. Its strongest factor is value.
CYPA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $39.17M
- Revenue (TTM)
- $583.34K
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 0.50
- 52-week high
- $3.00
- 52-week low
- $1.05
- Avg volume (3M)
- —
- Shares outstanding
- 32.10M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BF Biosciences LimitedKASE: BFBIO | $39.74M | PKRs124.67 | +1.71% |
| BioNxt Solutions Inc.CNSX: BNXT | $39.39M | CA$0.41 | +19.12% |
| InnoPharmax Inc.TPEX: 4172 | $39.26M | NT$10.45 | -2.79% |
| Trident Lifeline LimitedBSE: 543616 | $39.18M | Rs315.05 | +4.15% |
| biote Corp.NasdaqGM: BTMD | $39.00M | $1.36 | +0.74% |
| Botanix Pharmaceuticals LimitedASX: BOT | $38.91M | AU$0.02 | +5.26% |
| Astonea Labs LimitedBSE: 544409 | $38.83M | Rs354.50 | +22.66% |
| Medical Developments International LimitedASX: MVP | $38.44M | AU$0.48 | -4.00% |
Figures last refreshed Sep 20, 2026.